The VASCERN European Reference Network: An overview.

European reference network HHT Heritable thoracic aortic disease Lymphatic anomalies Vascular anomalies Vascular ehlers danlos

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 30 09 2021
revised: 03 01 2022
accepted: 03 01 2022
pubmed: 16 1 2022
medline: 5 4 2022
entrez: 15 1 2022
Statut: ppublish

Résumé

Established since 2017 and co-funded by the European commission, VASCERN is the European Reference Network aiming at improving and homogenizing care of patients with rare multisystemic vascular diseases throughout Europe. It gathers 31 expert teams from 26 highly specialized multidisciplinary HCPs, plus 7 Affiliated Partner centers, from 16 EU Member States, as well as more than 65 patient organisations (ePAG). It is structured around 5 main RDWGs, each specialized in a specific disease or group of diseases. It produces resources for doctors or patients in English, which are translated and used across Europe and the world. These resources include educational videos, guidelines, clinical outcome measures and expert consensus statements. Communication through VASCERN's social media channels and website ensure these valuable documents and media are shared across the EU and beyond. VASCERN's activities are enabled by the use of eHealth tools like the CPMS (Clinical Patient Management System), to discuss complex cases, and WebEx, for videoconferences. VASCERN also develops its own registry of rare vascular diseases, as well as a Mobile Application referencing all the expert centers and patient organisations in Europe to facilitate patient access to optimal care. Finally, VASCERN is coordinated at the Hopital Bichat-Claude Bernard in Paris by a team of 5, responsible for the organizational, technical, communication, administrative and budgetary tasks of the project. This review focuses on the notable achievements made in the first four years of the network and the challenges it still faces.

Identifiants

pubmed: 35032690
pii: S1769-7212(22)00001-5
doi: 10.1016/j.ejmg.2022.104420
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104420

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Auteurs

Guillaume Jondeau (G)

CRMR Syndrome de Marfan et apparentés, Service de Cardiologie, Hopital Bichat, Université de Paris, INSERM U1148, LVTS, Paris, France; VASCERN Coordination Team, Hopital Bichat, Paris, France. Electronic address: guillaume.jondeau@aphp.fr.

Julie Hallac (J)

VASCERN Coordination Team, Hopital Bichat, Paris, France.

Marine Hurard (M)

VASCERN Coordination Team, Hopital Bichat, Paris, France.

Karen Daoud (K)

VASCERN Coordination Team, Hopital Bichat, Paris, France.

Natasha Barr (N)

VASCERN Coordination Team, Hopital Bichat, Paris, France.

Ibrahim Domnez (I)

VASCERN Coordination Team, Hopital Bichat, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH